Becton Dickinson Q3 Beats Estimates On Medical Device Boom - Becton Dickinson (NYSE:BDX)
Summary by Benzinga
1 Articles
1 Articles
Becton Dickinson Q3 Beats Estimates On Medical Device Boom - Becton Dickinson (NYSE:BDX)
As the healthcare industry continues to rebound from global disruptions, companies like Becton, Dickinson, and Company (NYSE:BDX) are reporting robust financial performances that highlight their resilience and strategic adaptability. The company’s stock is trading higher on Thursday on better-than-expected third-quarter 2025 earnings. The medical device giant reported adjusted earnings per share of $3.68, up from $3.50 a year ago, beating the co…
·New York, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium